Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports

Epigenetic therapy with hypomethylating agent (5-azacytidine; AZA) is common in the management of specific subtypes of myelodysplastic syndrome (MDS), but there are only few studies in chronic myelomonocytic leukemia (CMML) patients. In this paper our experience with 3 CMML patients treated with AZA...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohon, Peter, Vondrakova, Jana, Jonasova, Anna, Holzerova, Milena, Jarosova, Marie, Indrak, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420792/
https://www.ncbi.nlm.nih.gov/pubmed/22937326
http://dx.doi.org/10.1155/2012/369086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420792/
https://www.ncbi.nlm.nih.gov/pubmed/22937326
http://dx.doi.org/10.1155/2012/369086

Ejemplares similares